no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity
|
Alter, Galit |
|
2015 |
33 |
S2 |
p. B55-B59 nvt p. |
article |
2 |
Beyond adjuvants: Immunomodulation strategies to enhance T cell immunity
|
Kamphorst, Alice O. |
|
2015 |
33 |
S2 |
p. B21-B28 nvt p. |
article |
3 |
Bridging the gap: Need for a data repository to support vaccine prioritization efforts
|
Madhavan, Guruprasad |
|
2015 |
33 |
S2 |
p. B34-B39 nvt p. |
article |
4 |
Challenges in early clinical development of adjuvanted vaccines
|
Della Cioppa, Giovanni |
|
2015 |
33 |
S2 |
p. B47-B51 nvt p. |
article |
5 |
Communicating the role and value of vaccine adjuvants
|
Gellin, Bruce G. |
|
2015 |
33 |
S2 |
p. B44-B46 nvt p. |
article |
6 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
S2 |
p. CO2- 1 p. |
article |
7 |
Gaps in knowledge and prospects for research of adjuvanted vaccines
|
Seder, Robert |
|
2015 |
33 |
S2 |
p. B40-B43 nvt p. |
article |
8 |
Introduction to the supplement
|
Rappuoli, Rino |
|
2015 |
33 |
S2 |
p. B1-B2 nvt p. |
article |
9 |
New generation adjuvants – From empiricism to rational design
|
O’Hagan, Derek T. |
|
2015 |
33 |
S2 |
p. B14-B20 nvt p. |
article |
10 |
Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults
|
Black, Steven |
|
2015 |
33 |
S2 |
p. B3-B5 nvt p. |
article |
11 |
The narcolepsy-pandemic influenza story: Can the truth ever be unraveled?
|
Sturkenboom, Miriam CJM |
|
2015 |
33 |
S2 |
p. B6-B13 nvt p. |
article |
12 |
The path forward
|
De Gregorio, Ennio |
|
2015 |
33 |
S2 |
p. B60-B63 nvt p. |
article |
13 |
Vaccines: From valuation to resource allocation
|
Bloom, David E. |
|
2015 |
33 |
S2 |
p. B52-B54 nvt p. |
article |
14 |
Valuing vaccines: Deficiencies and remedies
|
Bloom, David E. |
|
2015 |
33 |
S2 |
p. B29-B33 nvt p. |
article |